Shares of Crinetics Pharmaceuticals Inc. gained more than 4% premarket on Thursday after Oppenheimer analysts initiated coverage of the shares with an...
Shares of Crinetics Pharmaceuticals Inc.
gained more than 4% premarket on Thursday after Oppenheimer analysts initiated coverage of the shares with an outperform rating, calling Crinetics ‘drug hunters in their zone.’ Crinetics focuses on developing treatments for rare endocrine diseaess, an area where current drugs’ risk-benefit tradeoffs “leave much room for improvement, or approved options are outright lacking,” the analysts wrote in a note Wednesday.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pharmaceuticals News -- ScienceDailyResearch news on the pharmaceutical industry including new drugs and interventions.
Read more »
Alkermes shares surge after settlement with Teva on alcohol dependence treatmentShares of Alkermes PLC jumped 10% Wednesday after the Dublin-based biopharma company announced a settlement of patent litigation with Teva Pharmaceuticals...
Read more »
Factbox: Court challenges to Medicare drug price negotiation planThe U.S. government on Tuesday selected the first 10 drugs, including the big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer , that will be subject to the first-ever Medicare price negotiations, part of President Joe Biden’s Inflation Reduction Act (IRA) that drugmakers and industry groups have challenged in court.
Read more »
Biden targets diabetes drug Jardiance, blood thinner Eliquis and 8 others for Medicare price talksPresident Joe Biden says for many Americans the cost of one drug can be “the difference between life and death” as his administration announces the first drugs that’ll be targeted for price negotiations in an effort to cut Medicare costs
Read more »
Biden administration targets diabetes drug, blood thinner, others for Medicare price negotiationsA popular diabetes treatment and the blood thinner Eliquis are among the first drugs that'll be targeted for price negotiations in an effort to cut Medicare costs.
Read more »
Biden targets diabetes drug Jardiance, blood thinner Eliquis and 8 others for Medicare price talksPresident Joe Biden’s administration on Tuesday released a list of 10 drugs for which the federal government will take a first-ever step: negotiating drug prices directly with the manufacturer.
Read more »